In vitro anti-HIV activity of some Indian medicinal plant extracts.


Journal

BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232

Informations de publication

Date de publication:
06 Mar 2020
Historique:
received: 18 07 2019
accepted: 15 01 2020
entrez: 8 3 2020
pubmed: 8 3 2020
medline: 5 9 2020
Statut: epublish

Résumé

Human Immunodeficiency Virus (HIV) persists to be a significant public health issue worldwide. The current strategy for the treatment of HIV infection, Highly Active Antiretroviral Therapy (HAART), has reduced deaths from AIDS related disease, but it can be an expensive regime for the underdeveloped and developing countries where the supply of drugs is scarce and often not well tolerated, especially in persons undergoing long term treatment. The present therapy also has limitations of development of multidrug resistance, thus there is a need for the discovery of novel anti-HIV compounds from plants as a potential alternative in combating HIV disease. Ten Indian medicinal plants were tested for entry and replication inhibition against laboratory adapted strains HIV-1 The methanolic extracts of Achyranthes aspera, Rosa centifolia and aqueous extract of Ficus benghalensis inhibited laboratory adapted HIV-1 strains (IC These active methanolic extracts of Achyranthes aspera and Rosa centifolia, could be further subjected to chemical analysis to investigate the active moiety responsible for the anti-HIV activity. Methanolic extract of Rosa centifolia was found to be well tolerated maintaining the epithelial integrity of HEC-1A cells in vitro and thus has potential for investigating it further as candidate microbicide.

Sections du résumé

BACKGROUND BACKGROUND
Human Immunodeficiency Virus (HIV) persists to be a significant public health issue worldwide. The current strategy for the treatment of HIV infection, Highly Active Antiretroviral Therapy (HAART), has reduced deaths from AIDS related disease, but it can be an expensive regime for the underdeveloped and developing countries where the supply of drugs is scarce and often not well tolerated, especially in persons undergoing long term treatment. The present therapy also has limitations of development of multidrug resistance, thus there is a need for the discovery of novel anti-HIV compounds from plants as a potential alternative in combating HIV disease.
METHODS METHODS
Ten Indian medicinal plants were tested for entry and replication inhibition against laboratory adapted strains HIV-1
RESULTS RESULTS
The methanolic extracts of Achyranthes aspera, Rosa centifolia and aqueous extract of Ficus benghalensis inhibited laboratory adapted HIV-1 strains (IC
CONCLUSION CONCLUSIONS
These active methanolic extracts of Achyranthes aspera and Rosa centifolia, could be further subjected to chemical analysis to investigate the active moiety responsible for the anti-HIV activity. Methanolic extract of Rosa centifolia was found to be well tolerated maintaining the epithelial integrity of HEC-1A cells in vitro and thus has potential for investigating it further as candidate microbicide.

Identifiants

pubmed: 32143607
doi: 10.1186/s12906-020-2816-x
pii: 10.1186/s12906-020-2816-x
pmc: PMC7076815
doi:

Substances chimiques

Plant Extracts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Subventions

Organisme : Department of Biotechnology , Ministry of Science and Technology
ID : BT/PR7965/Med/14/1203/2006
Organisme : Department of Biotechnology , Ministry of Science and Technology
ID : BT/PR7965/Med/14/1203/2006, Dated 20 Oct 2006

Références

J Virol Methods. 2014 Jul;203:88-96
pubmed: 24698763
Curr Pharm Des. 2005;11(29):3731-46
pubmed: 16305508
J Ethnopharmacol. 2005 Oct 3;101(1-3):55-60
pubmed: 15923095
Ethiop Med J. 2006 Oct;44(4):405-15
pubmed: 17370443
Asian J Androl. 2004 Jun;6(2):155-9
pubmed: 15154091
J Nat Prod. 1998 Sep;61(9):1090-5
pubmed: 9748372
Cancer Lett. 2002 Mar 8;177(1):1-5
pubmed: 11809524
Molecules. 2013 Apr 16;18(4):4477-86
pubmed: 23591927
J Ethnopharmacol. 1996 Aug;53(2):97-104
pubmed: 8844464
Chem Cent J. 2013 Sep 17;7(1):157
pubmed: 24041220
Nat Prod Res. 2015;29(16):1562-6
pubmed: 25427632
Curr Pharm Des. 2004;10(3):315-36
pubmed: 14754390
J Ethnopharmacol. 2006 Apr 21;105(1-2):154-60
pubmed: 16388923
Contraception. 2010 Apr;81(4):355-61
pubmed: 20227555
Chem Pharm Bull (Tokyo). 2002 Dec;50(12):1566-9
pubmed: 12499591
Indian J Clin Biochem. 2008 Oct;23(4):394-400
pubmed: 23105795
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
pubmed: 12019106
Microbiol Res. 2013 May 6;168(4):238-44
pubmed: 23218996
Fitoterapia. 2011 Jun;82(4):666-75
pubmed: 21342663
J Virol. 1995 Jun;69(6):3712-20
pubmed: 7745720
J Virol. 2010 Sep;84(17):8360-8
pubmed: 20375157
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
Virol J. 2013 Oct 18;10:309
pubmed: 25228267
Contraception. 2012 Jan;85(1):122-7
pubmed: 22067802
Indian J Exp Biol. 1992 Feb;30(2):128-30
pubmed: 1521862
Life Sci. 2003 May 9;72(25):2853-61
pubmed: 12697268
Fitoterapia. 2002 Feb;73(1):43-7
pubmed: 11864763
J Ethnopharmacol. 1996 Jul 5;52(3):157-63
pubmed: 8771457
FEBS Lett. 1991 Jul 29;286(1-2):83-5
pubmed: 1713859
J Nat Prod. 1996 Jun;59(6):635-7
pubmed: 8786370
Reprod Toxicol. 2005 May-Jun;20(1):149-56
pubmed: 15808798
J Virol. 2003 Nov;77(22):12105-12
pubmed: 14581547
J Ethnopharmacol. 2004 May;92(1):47-51
pubmed: 15099846
Antimicrob Agents Chemother. 2010 Dec;54(12):5105-14
pubmed: 20921308
Nat Prod Res. 2014;28(4):245-50
pubmed: 24099509
Planta Med. 1998 Mar;64(2):97-109
pubmed: 9525100
Indian J Biochem Biophys. 2004 Aug;41(4):167-72
pubmed: 22900348
Nat Prod Res. 2007 Dec;21(14):1266-70
pubmed: 18075889
Indian J Exp Biol. 2007 May;45(5):480-5
pubmed: 17569293
Planta Med. 2008 Mar;74(4):413-6
pubmed: 18484534
Afr Health Sci. 2006 Jun;6(2):108-12
pubmed: 16916302
BMC Complement Altern Med. 2010 Oct 13;10:56
pubmed: 20939932
Nat Rev Immunol. 2006 May;6(5):371-82
pubmed: 16639430
Biochim Biophys Acta. 2002 Jul 18;1587(2-3):258-75
pubmed: 12084468
Pharmacogn Rev. 2014 Jan;8(15):61-6
pubmed: 24600197
Phytomedicine. 2007 May;14(5):360-5
pubmed: 17317130

Auteurs

Aparna Palshetkar (A)

C. U Shah College of Pharmacy, S.N.D.T. Women's University, Santacruz West, Mumbai, 400049, India.

Navin Pathare (N)

National AIDS Research Institute, 73, 'G'-Block, MIDC, Bhosari, Pune, 411 026, India.

Nutan Jadhav (N)

National AIDS Research Institute, 73, 'G'-Block, MIDC, Bhosari, Pune, 411 026, India.

Megha Pawar (M)

National AIDS Research Institute, 73, 'G'-Block, MIDC, Bhosari, Pune, 411 026, India.

Ashish Wadhwani (A)

National AIDS Research Institute, 73, 'G'-Block, MIDC, Bhosari, Pune, 411 026, India.

Smita Kulkarni (S)

National AIDS Research Institute, 73, 'G'-Block, MIDC, Bhosari, Pune, 411 026, India. skulkarni@nariindia.org.

Kamalinder K Singh (KK)

C. U Shah College of Pharmacy, S.N.D.T. Women's University, Santacruz West, Mumbai, 400049, India. ksingh1@uclan.ac.uk.
School of Pharmacy and Biomedical Sciences, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire, Preston, PR1 2HE, UK. ksingh1@uclan.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH